Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Raysearch Laboratories

219.80 SEK

+3.48 %

Less than 1K followers

RAY B

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Raysearch Laboratories

2019202020212022202320242025
Revenue741.6651.6641.1843.71,022.21,192.01,344.3
growth-%-12.1 %-1.6 %31.6 %21.2 %16.6 %12.8 %
EBITDA250.7209.8196.7339.7400.1558.0583.6
EBIT68.2-3.5-53.542.7114.9260.5292.3
Profit before taxes62.6-6.5-58.932.4110.1262.9287.8
Net income50.4-9.1-47.323.881.6203.5227.8
EPS1.47-0.26-1.380.692.385.946.65
Dividend0.000.000.000.002.003.004.00
Dividend ratio0.0 %-0.0 %-0.0 %0.0 %84.0 %50.5 %60.2 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%33.8 %32.2 %30.7 %40.3 %39.1 %46.8 %43.4 %
EBIT-%9.2 %-0.5 %-8.3 %5.1 %11.2 %21.9 %21.7 %
ROE7.1 %-1.3 %-7.3 %3.6 %11.1 %23.2 %23.1 %
ROI4.0 %-0.7 %-2.7 %1.3 %4.2 %9.7 %11.4 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.